Tengion Revenue and Competitors

East Norriton, PA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Tengion's estimated annual revenue is currently $4.3M per year.(i)
  • Tengion's estimated revenue per employee is $155,000

Employee Data

  • Tengion has 28 Employees.(i)
  • Tengion grew their employee count by -3% last year.

Tengion's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.6M100%N/AN/A
#2
$4M2613%N/AN/A
#3
$0.9M6-14%N/AN/A
#4
$1.1M70%N/AN/A
#5
$10.9M703%N/AN/A
#6
$0.7M929%N/AN/A
#7
$4M26-16%N/AN/A
#8
$1.7M1122%N/AN/A
#9
$7.6M492%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Tengion?

Tengion, a clinical-stage biotechnology company, has pioneered the Organ Regeneration Platformâ„¢ that enables the Company to create proprietary product candidates that are intended to harness the intrinsic regenerative pathways of the body to produce a range of native-like organs and tissues. Tengion's product candidates seek to eliminate the need to utilize other tissues of the body for a purpose to which they are poorly suited, procure donor organs or administer anti-rejection medications. An initial clinical trial is ongoing for the Company's lead product candidate, the Neo-Urinary Conduitâ„¢, an autologous implant that is intended to catalyze regeneration of native-like bladder tissue for bladder cancer patients requiring a urinary diversion following bladder removal. The Company's lead preclinical program is the Neo-Kidney Augmentâ„¢, which is designed to delay or prevent the need for dialysis or transplantation in patients at risk for kidney failure. Tengion has also applied its technology in two Phase II clinical trials for Tengion's Neo-Bladder Augmentâ„¢ for the treatment of neurogenic bladder. Tengion has worldwide rights to its product candidates.

keywords:N/A

N/A

Total Funding

28

Number of Employees

$4.3M

Revenue (est)

-3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M28-10%N/A
#2
$17.8M81-5%N/A